Skip to content

Author

N. Schmidt

We have 4 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Safety and surgical outcomes of sodium fluorescein-guided pediatric brain tumor surgery: a retrospective before-and-after single-center cohort study

Sodium fluorescein (SF) used with a YELLOW 560-nm filter may improve intraoperative visualization of contrast-enhancing brain tumors, but pediatric evidence remains limited. We assessed the feasibility, safety, and surgical outcomes of SF-guided resection in a single-center pediatric cohort. We retrospecti...

Christian Ott, Alexander Hebeler, T. Araceli et al. · 0 citations
Open access Aug 2026

NOTQ-07 PREOPERATIVE NEUROLOGICAL IMPAIRMENT AND FUNCTIONAL STATUS IN INFILTRATIVE VERSUS NON-INFILTRATIVE BRAIN METASTASES: A COMPARATIVE STUDY

Infiltrative BM are associated with reduced presurgical functional status and a markedly higher frequency of hemiparesis, aphasia, and seizures, indicating an increased neurological burden prior to surgical treatment.

T. Araceli, R. Blazquez, E. Stoerr et al. · 0 citations
Open access Aug 2026

Complication profile of two surgical techniques, neurosurgical experience, and operative setting for pediatric external ventricular drainage implantation

External ventricular drain (EVD) insertion, a standard procedure for treating acute hydrocephalus, is also associated with significant risks. This retrospective study compares two surgical techniques routinely employed at our clinic and analyzes the influence of surgeon experience and the operative setting on complicat...

T. Araceli, Sarah Klarner, F. Zeman et al. · 0 citations
Open access Aug 2026

SADA-19 SURGICAL OUTCOMES IN CEREBELLAR BRAIN METASTASES: A MULTICENTER COHORT STUDY

In this contemporary multicenter cohort of 201 patients, surgical resection of cerebellar metastases achieved a median survival of about one year, and functional status and systemic disease burden remain the strongest predictors of outcome.

T. Araceli, Matthias Demetz, J. Rösler et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.